Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Web Sites |
     
  3. Global Business Websites |
     
  4. Contact Us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

Your Health

Contact Us

Sanofi Ireland Ltd.

18 Riverwalk
Citywest Business Campus
Dublin 24

Tel : + 353 (0)1 403 5600

Content :

Cardiovascular

Cardiovascular

As one of the main causes of death and acquired disability, cardiovascular disease is a major healthcare priority throughout the industrialised world.

 

What is Cardiovascular Disease (CVD)?

CVD is the name for the group of disorders affecting the heart and blood vessels. The main forms of CVD are coronary heart disease (CHD), stroke, thrombosis and peripheral artery disease (PAD). CHD and stroke are both often caused by a blockage in an artery.

Our Commitment

Sanofi is committed to developing world-class pharmaceutical products to prevent and treat cardiovascular diseases. We currently market cardiovascular drugs for the treatment of hypertension and congestive heart failure, and for the reduction of events such as heart attack, stroke, vascular death, or cardiovascular death.

  • Aprovel® (irbesartan)

  • Plavix® (clopidogrel hydrogen sulphate)

  • Triapin® (ramipril / felodipine)

  • Tritace® (ramipril)

Module :